|Dr. David Sparling L.L.B., BVSc (Hons), GDipAppCGov, LLB (Hons)||CEO & Joint Company Sec.||412.56k||N/A||N/A|
|Ms. Ancila Desai||CFO & Joint Company Sec.||222.42k||N/A||N/A|
|Mr. Jim Sosic||VP of Operations, Supply & Infrastructure||231.59k||N/A||N/A|
|Paul McDonald||Head of Quality & Devel.||N/A||N/A||N/A|
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. The company offers analytical method development, stability chambers, and chemistry and microbiology quality control laboratory services, as well as pharmaceutical development services in all dosage forms. Its services also include project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs. In addition, the company offers medical cannabis products; and various contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
IDT Australia Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.